trial · primary record
JNJ-89862175
Advanced-stage Solid Tumors
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 360 |
| Primary completion | 2028-08-15 |
| Primary endpoint | Part 1: Number of Participants with Dose-Limiting Toxicity (DLTs) |
| Registry ID | NCT07223125 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:53.587Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07223125
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.